Cargando…
Identification of a prognostic evaluator from glutamine metabolic heterogeneity studies within and between tissues in hepatocellular carcinoma
Background: The liver is the major metabolic organ of the human body, and abnormal metabolism is the main factor influencing hepatocellular carcinoma (HCC). This study was designed to determine the effect of glutamine metabolism on HCC heterogeneity and to develop a prognostic evaluator based on the...
Autores principales: | Bao, Jie, Yu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637396/ https://www.ncbi.nlm.nih.gov/pubmed/37954858 http://dx.doi.org/10.3389/fphar.2023.1241677 |
Ejemplares similares
-
Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023) -
Heterogeneity characterization of hepatocellular carcinoma based on the sensitivity to 5-fluorouracil and development of a prognostic regression model
por: Gu, Xinyu, et al.
Publicado: (2023) -
Identification and validation in a novel quantification system of the glutamine metabolism patterns for the prediction of prognosis and therapy response in hepatocellular carcinoma
por: Jin, Shengjie, et al.
Publicado: (2022) -
Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
por: Zhou, Zheng, et al.
Publicado: (2022) -
Ganfule capsule alleviates bile duct ligation-induced liver fibrosis in mice by inhibiting glutamine metabolism
por: Ke, Chang, et al.
Publicado: (2022)